# Limelight Bio, Inc. — Form D

Limelight Bio, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-15. The offering totals $50.0M, of which $14.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-08-15
- Form: D
- Accession: 0001567619-19-017091
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $14.0M
- Remaining: $36.0M
- Investors: 7
- Date of first sale: 2016-03-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-346678

## Issuer

- Name: Limelight Bio, Inc.
- CIK: 0001785544
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 3401 GRAYS FERRY AVENUE, PHILADELPHIA, PA, 19146
- Phone: 267-519-2985

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Seth L Harrison | Director | — |
| Philip R Johnson | Director | Philadelphia, PA |
| Philip R Johnson | Executive Officer | Philadelphia, PA |
| David L Shin | Executive Officer | Philadelphia, PA |

## More

- [CIK 1785544 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1785544&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-19-017091.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.